Owens & Minor (NYSE:OMI) Releases Earnings Results, Beats Estimates By $0.03 EPS

Share on StockTwits

Owens & Minor (NYSE:OMI) announced its quarterly earnings data on Wednesday. The company reported $0.10 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.07 by $0.03, Briefing.com reports. The company had revenue of $2.48 billion for the quarter, compared to analysts’ expectations of $2.44 billion. Owens & Minor had a positive return on equity of 6.92% and a negative net margin of 4.63%. Owens & Minor’s revenue for the quarter was up 1.1% compared to the same quarter last year. During the same period last year, the firm posted $0.32 EPS. Owens & Minor updated its FY 2019 guidance to $0.60-0.70 EPS.

OMI traded up $1.22 on Wednesday, hitting $4.07. 6,438,400 shares of the company were exchanged, compared to its average volume of 1,489,437. The stock’s fifty day moving average price is $2.98. The company has a quick ratio of 0.89, a current ratio of 1.75 and a debt-to-equity ratio of 3.67. Owens & Minor has a 12 month low of $2.43 and a 12 month high of $18.40. The company has a market capitalization of $181.26 million, a PE ratio of 3.54, a PEG ratio of 1.37 and a beta of 1.74.

Institutional investors and hedge funds have recently bought and sold shares of the stock. FMR LLC grew its position in Owens & Minor by 159,300.0% during the 4th quarter. FMR LLC now owns 4,782 shares of the company’s stock worth $30,000 after acquiring an additional 4,779 shares during the last quarter. Atlantic Union Bankshares Corp bought a new position in Owens & Minor during the 2nd quarter worth approximately $36,000. Stone Ridge Asset Management LLC bought a new position in Owens & Minor during the 2nd quarter worth approximately $50,000. First Trust Advisors LP bought a new position in Owens & Minor during the 1st quarter worth approximately $56,000. Finally, First Allied Advisory Services Inc. bought a new position in Owens & Minor during the 4th quarter worth approximately $71,000. Institutional investors and hedge funds own 88.98% of the company’s stock.

OMI has been the topic of a number of research reports. Bank of America reissued a “neutral” rating and set a $4.50 price objective (down from $7.00) on shares of Owens & Minor in a report on Wednesday, April 10th. ValuEngine cut Owens & Minor from a “sell” rating to a “strong sell” rating in a report on Thursday, August 1st. Finally, Zacks Investment Research raised Owens & Minor from a “hold” rating to a “buy” rating and set a $3.25 price objective on the stock in a report on Friday, July 19th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the stock. Owens & Minor has a consensus rating of “Hold” and a consensus target price of $6.13.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.

Read More: Cash Asset Ratio

Earnings History for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Gateley Holdings PLC  to Distribute Dividend of GBX 5.40 on  October 16th
Gateley Holdings PLC to Distribute Dividend of GBX 5.40 on October 16th
Equiniti Group PLC Plans Dividend of GBX 1.95
Equiniti Group PLC Plans Dividend of GBX 1.95
Armada Hoffler Properties  & Nam Tai Property  Head-To-Head Review
Armada Hoffler Properties & Nam Tai Property Head-To-Head Review
Critical Comparison: Taro Pharmaceutical Industries  and Genmab A/S
Critical Comparison: Taro Pharmaceutical Industries and Genmab A/S
Critical Comparison: Jerash Holdings   versus Its Rivals
Critical Comparison: Jerash Holdings versus Its Rivals
Comparing Symantec  & Tyler Technologies
Comparing Symantec & Tyler Technologies


 
© 2006-2019 Zolmax.